Literature DB >> 34298806

Accelerated T2-Weighted TSE Imaging of the Prostate Using Deep Learning Image Reconstruction: A Prospective Comparison with Standard T2-Weighted TSE Imaging.

Sebastian Gassenmaier1, Saif Afat1, Marcel Dominik Nickel2, Mahmoud Mostapha3, Judith Herrmann1, Haidara Almansour1, Konstantin Nikolaou1,4, Ahmed E Othman1,5.   

Abstract

Multiparametric MRI (mpMRI) of the prostate has become the standard of care in prostate cancer evaluation. Recently, deep learning image reconstruction (DLR) methods have been introduced with promising results regarding scan acceleration. Therefore, the aim of this study was to investigate the impact of deep learning image reconstruction (DLR) in a shortened acquisition process of T2-weighted TSE imaging, regarding the image quality and diagnostic confidence, as well as PI-RADS and T2 scoring, as compared to standard T2 TSE imaging. Sixty patients undergoing 3T mpMRI for the evaluation of prostate cancer were prospectively enrolled in this institutional review board-approved study between October 2020 and March 2021. After the acquisition of standard T2 TSE imaging (T2S), the novel T2 TSE sequence with DLR (T2DLR) was applied in three planes. Overall, the acquisition time for T2S resulted in 10:21 min versus 3:50 min for T2DLR. The image evaluation was performed by two radiologists independently using a Likert scale ranging from 1-4 (4 best) applying the following criteria: noise levels, artifacts, overall image quality, diagnostic confidence, and lesion conspicuity. Additionally, T2 and PI-RADS scoring were performed. The mean patient age was 69 ± 9 years (range, 49-85 years). The noise levels and the extent of the artifacts were evaluated to be significantly improved in T2DLR versus T2S by both readers (p < 0.05). Overall image quality was also evaluated to be superior in T2DLR versus T2S in all three acquisition planes (p = 0.005-<0.001). Both readers evaluated the item lesion conspicuity to be superior in T2DLR with a median of 4 versus a median of 3 in T2S (p = 0.001 and <0.001, respectively). T2-weighted TSE imaging of the prostate in three planes with an acquisition time reduction of more than 60% including DLR is feasible with a significant improvement of image quality.

Entities:  

Keywords:  deep learning; diagnostic imaging; multiparametric magnetic resonance imaging; prostatic neoplasms

Year:  2021        PMID: 34298806     DOI: 10.3390/cancers13143593

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  5 in total

1.  Highly accelerated 3D MPRAGE using deep neural network-based reconstruction for brain imaging in children and young adults.

Authors:  Woojin Jung; JeeYoung Kim; Jingyu Ko; Geunu Jeong; Hyun Gi Kim
Journal:  Eur Radiol       Date:  2022-03-22       Impact factor: 7.034

2.  Reduction in Acquisition Time and Improvement in Image Quality in T2-Weighted MR Imaging of Musculoskeletal Tumors of the Extremities Using a Novel Deep Learning-Based Reconstruction Technique in a Turbo Spin Echo (TSE) Sequence.

Authors:  Daniel Wessling; Judith Herrmann; Saif Afat; Dominik Nickel; Ahmed E Othman; Haidara Almansour; Sebastian Gassenmaier
Journal:  Tomography       Date:  2022-07-06

3.  Feasibility of an accelerated 2D-multi-contrast knee MRI protocol using deep-learning image reconstruction: a prospective intraindividual comparison with a standard MRI protocol.

Authors:  Judith Herrmann; Gabriel Keller; Sebastian Gassenmaier; Dominik Nickel; Gregor Koerzdoerfer; Mahmoud Mostapha; Haidara Almansour; Saif Afat; Ahmed E Othman
Journal:  Eur Radiol       Date:  2022-04-07       Impact factor: 7.034

4.  Clinical Evaluation of an Abbreviated Contrast-Enhanced Whole-Body MRI for Oncologic Follow-Up Imaging.

Authors:  Judith Herrmann; Saif Afat; Andreas Brendlin; Maryanna Chaika; Andreas Lingg; Ahmed E Othman
Journal:  Diagnostics (Basel)       Date:  2021-12-16

Review 5.  Deep Learning Applications in Magnetic Resonance Imaging: Has the Future Become Present?

Authors:  Sebastian Gassenmaier; Thomas Küstner; Dominik Nickel; Judith Herrmann; Rüdiger Hoffmann; Haidara Almansour; Saif Afat; Konstantin Nikolaou; Ahmed E Othman
Journal:  Diagnostics (Basel)       Date:  2021-11-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.